Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学GI Neuroendocrine Tumors

Matthew Kulke

MD

🏢Boston Medical Center, Boston University🌐USA

Professor of Medicine

66
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Matthew Kulke is a foremost authority on gastrointestinal neuroendocrine tumors with decades of experience leading pivotal clinical trials. He has contributed to establishing everolimus and sunitinib as standards of care for advanced pancreatic NETs. His work encompasses biomarker discovery, quality-of-life outcomes, and novel systemic therapies for carcinoid tumors. He has served on NCCN and other guideline committees shaping NET management globally.

Share:

🧪Research Fields 研究领域

gastrointestinal NETs
carcinoid syndrome
everolimus NETs
sunitinib NETs
neuroendocrine tumor clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Matthew Kulke 的研究动态

Follow Matthew Kulke's research updates

留下邮箱,当我们发布与 Matthew Kulke(Boston Medical Center, Boston University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment